These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 1576619

  • 21. Gentamicin. Clinical and pharmacological studies.
    Holloway WJ.
    Int Z Klin Pharmakol Ther Toxikol; 1970 May; 3(2):122-7. PubMed ID: 4913081
    [No Abstract] [Full Text] [Related]

  • 22. Antimicrobial resistance of urinary tract pathogens in children in Crete, Greece.
    Anatoliotaki M, Galanakis E, Schinaki A, Stefanaki S, Mavrokosta M, Tsilimigaki A.
    Scand J Infect Dis; 2007 May; 39(8):671-5. PubMed ID: 17654342
    [Abstract] [Full Text] [Related]

  • 23. The diffusion and concentration of trimethoprim in human vaginal fluid.
    Stamey TA, Condy M.
    J Infect Dis; 1975 Mar; 131(3):261-6. PubMed ID: 1092766
    [Abstract] [Full Text] [Related]

  • 24. A pilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection.
    Uehara S, Monden K, Nomoto K, Seno Y, Kariyama R, Kumon H.
    Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S30-4. PubMed ID: 16859900
    [Abstract] [Full Text] [Related]

  • 25. Management of urinary tract infections: historical perspective and current strategies: Part 2--Modern management.
    Nickel JC.
    J Urol; 2005 Jan; 173(1):27-32. PubMed ID: 15592019
    [Abstract] [Full Text] [Related]

  • 26. Cephalexin monohydrate in the treatment of urinary tract infections and urethritis.
    Rocha H, Peltier Queiroz F.
    Prensa Med Mex; 1970 Jan; ():56-60. PubMed ID: 4931118
    [No Abstract] [Full Text] [Related]

  • 27. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
    Guneysel O, Onur O, Erdede M, Denizbasi A.
    J Emerg Med; 2009 May; 36(4):338-41. PubMed ID: 18325714
    [Abstract] [Full Text] [Related]

  • 28. Urinary infections due to multi-drug-resistant Escherichia coli among persons with HIV disease at a tertiary AIDS care centre in South India.
    Vignesh R, Shankar EM, Murugavel KG, Kumarasamy N, Sekar R, Irene P, Solomon S, Balakrishnan P.
    Nephron Clin Pract; 2008 May; 110(1):c55-7. PubMed ID: 18724067
    [Abstract] [Full Text] [Related]

  • 29. Escherichia coli resistance in uncomplicated urinary tract infection: a model for determining when to change first-line empirical antibiotic choice.
    Perfetto EM, Gondek K.
    Manag Care Interface; 2002 Jun; 15(6):35-42. PubMed ID: 12087605
    [Abstract] [Full Text] [Related]

  • 30. Clinical evaluation of cephalexin in urinary tract infection.
    Kawamura J.
    Postgrad Med J; 1970 Oct; ():Suppl:28-30. PubMed ID: 4922708
    [No Abstract] [Full Text] [Related]

  • 31. Treatment of urinary tract infections in Hong Kong: a comparative study of norfloxacin and co-trimoxazole.
    Wong WT, Chan MK, Li MK, Wong WS, Yin PD, Cheng IK.
    Scand J Infect Dis Suppl; 1988 Oct; 56():22-7. PubMed ID: 3074462
    [Abstract] [Full Text] [Related]

  • 32. [The role of ampicillin in antibiotic therapy with special reference to laboratory findings].
    Legler F.
    Arzneimittelforschung; 1966 Jul; 16(7):814-8. PubMed ID: 4870009
    [No Abstract] [Full Text] [Related]

  • 33. Norfloxacin treatment in complicated urinary tract infection.
    Boerema JB, van Saene HK.
    Scand J Infect Dis Suppl; 1986 Jul; 48():20-6. PubMed ID: 3465030
    [Abstract] [Full Text] [Related]

  • 34. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
    Brown PD, Freeman A, Foxman B.
    Clin Infect Dis; 2002 Apr 15; 34(8):1061-6. PubMed ID: 11914994
    [Abstract] [Full Text] [Related]

  • 35. [Antibiotic resistance among E. coli isolates from urinary tract infections (1999-2000): a multicenter study].
    Smaoui H, Mahjoubi F, Boutiba I, Jouaihia W, Thabet L, Znazen A, Kammoun A, Mezghanni S, Triki O, Hammami A, Ben Hassen A, Kechrid A, Ben Redjeb S.
    Tunis Med; 2003 Jun 15; 81(6):390-4. PubMed ID: 14534944
    [Abstract] [Full Text] [Related]

  • 36. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Zhanel GG, Hisanaga TL, Laing NM, DeCorby MR, Nichol KA, Palatnik LP, Johnson J, Noreddin A, Harding GK, Nicolle LE, Hoban DJ, NAUTICA Group.
    Int J Antimicrob Agents; 2005 Nov 15; 26(5):380-8. PubMed ID: 16243229
    [Abstract] [Full Text] [Related]

  • 37. [Effectiveness and tolerance of norfloxacin compared with trimethoprim-sulfamethoxazole in the treatment of uncomplicated urinary tract infections].
    Ballesteros JJ, Salvador M, Macías J, Honorato J, Rubio A, Azanza JR.
    Rev Med Univ Navarra; 1988 Nov 15; 32(3):135-7. PubMed ID: 3070683
    [Abstract] [Full Text] [Related]

  • 38. Single-dose compared with 3-day norfloxacin treatment of uncomplicated urinary tract infection in women. Canadian Infectious Diseases Society Clinical Trials Study Group.
    Saginur R, Nicolle LE.
    Arch Intern Med; 1992 Jun 15; 152(6):1233-7. PubMed ID: 1599352
    [Abstract] [Full Text] [Related]

  • 39. Uncomplicated urinary tract infections: lomefloxacin versus trimethoprim/sulphamethoxazole.
    Guibert J, Capron MH.
    J Int Med Res; 1992 Nov 15; 20(6):467-74. PubMed ID: 1337525
    [Abstract] [Full Text] [Related]

  • 40. Trimethoprim-sulfamethoxazole in recurrent urinary tract infection in children.
    Forbes PA, Drummond KN.
    J Infect Dis; 1973 Nov 15; 128():Suppl:626-8 p. PubMed ID: 4585961
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.